Rare DDX3X Gene Mutation in a Male Newborn With Super-refractory Status Epilepticus Responding to Lacosamide Drug Therapy
Noora BaniHammad, Raafat Hamad Seroor H Jadah · 2024
Read Rare DDX3X Gene Mutation in a Male Newborn With Super-refractory Status Epilepticus Responding to Lacosamide Drug Therapy by Noora BaniHammad, Raafat Hamad Seroor H Jadah (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11724213.txt.
Description
Noora BaniHammad and Raafat Jadah (2024) report a newborn boy whose seizures would not stop, and the drug that finally quieted them. His condition was super-refractory status epilepticus: seizures that persist or return even after a day of anesthetic treatment. Standard drugs failed in sequence, benzodiazepines, phenobarbital, levetiracetam, and a midazolam infusion. Genetic testing found a rare mutation in DDX3X, a gene whose disorders usually affect girls and involve development of the brain.
As a third-line agent the team added lacosamide. The drug works unusually, easing sodium channels into their slow off state rather than slamming them shut. The case describes the infant's response after lacosamide joined the regimen. Single cases cannot prove a treatment, but in a condition where hours of seizing damage the brain, a documented success in a genetic case gives the next team a place to start.
Catalog record
| CREATOR | Noora BaniHammad, Raafat Hamad Seroor H Jadah |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |